The additional shares purchased with reinvested dividends will themselves pay dividends.
Once you have the initial cost basis for the shares, you'll need to continue to add the cost of
additional shares purchased to that basis.
(a. 1) When dividends are DRIP'd people reduce the $ Cost by ignoring the cost of
the additional shares purchased using the dividends received.
The additional shares purchased with reinvested dividends have grown the portfolio enough so that its overall income rises faster than the dividend growth rate of any stock in it.
Your financial professional is a great resource for
additional share purchases and other account transactions.
In addition, the Funds may limit
additional share purchases or close an account if it is unable to verify a shareholder's identity.
Not exact matches
HOUSTON, April 20, 2018 (GLOBE NEWSWIRE)-- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) a clinical stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders, today announced the closing of its previously announced underwritten public offering of 9,200,000
shares of its common stock, including 1,200,000
shares sold pursuant to the underwriters» full exercise of their option to
purchase additional shares, at a public offering price of $ 7.50 per
share.
«However, Berkshire routinely assesses market conditions and may decide to
purchase additional shares of common stock of Wells Fargo based on its evaluation of the investment opportunity presented by such
purchases.»
Mineral sands explorer Sheffield Resources has raised $ 5 million for its Thunderbird project, and plans to bring in an
additional $ 2 million via a
share purchase plan.
And more
shares could be released if banking underwriters exercise their option to
purchase additional shares (an option all banks retain when guiding a company to the public market).
In addition to the 2.04 million treasury
shares currently held, the company plans to
purchase and retire
additional treasury
shares worth 187.5 billion won over three years from next year, with 62.5 billion won to be retired each year.
Bellicum expects to grant the underwriters of the offering a 30 - day option to
purchase up to an
additional 1,050,000
shares of its common stock at the public offering price, less the underwriting discounts and commissions.
Pursuant to the offering, Centene granted the underwriters an option to
purchase from the Company up to an
additional $ 260 million in
shares of common stock.
Charoen gained the upper hand when he amassed a stake of more than 40 percent in F&N by
purchasing an
additional 90.8 million
shares, or a 6.3 percent stake in F&N, at S$ 9.55 each on Friday and another 2.2 million
shares on Saturday.
There were also employee
share options outstanding to
purchase up to an
additional 3.4 million
shares, at a weighted average exercise price of $ 31.37 per
share, 0.8 million of which were fully vested; equity - settled
share appreciation rights (SARs) for 0.2 million
shares, at a weighted average measurement price of $ 32.18, all of which, excluding SARs for approximately 1,000
shares, were fully vested; and restricted
share units (RSUs) covering 13.0 million
shares, of which RSUs to acquire 4.3 million
shares were fully vested.
Cenovus has granted the underwriters an over-allotment option to
purchase up to an
additional 10.125 million common
shares at the offering price for up to 30 days after closing.
• Most DRIPs permit investors to send optional cash payments (OCPs), in many cases for as little as $ 25 to $ 50, directly to the company to
purchase additional shares.
Should the deal's underwriters exercise an option to
purchase up to 2.4 million
additional shares, Ardagh said it could raise as much as $ 372.6 million (352.2 million euros) at the top of its price range.
• OCP is the abbreviation used for Optional Cash Payments — the voluntary payments that shareholders may make directly into the DRIP in order to
purchase additional shares.
Investors
purchase shares with dividends that the company reinvests for them in
additional shares.
The bank has granted the Underwriters an option, exercisable in whole or in part, to
purchase up to an
additional 2 million Preferred
Shares Series BK at the same offering price.
DALLAS, April 19, 2017 / PRNewswire / — NexPoint Credit Strategies Fund (NYSE: NHF)(the «Fund») today announced the commencement of a non-transferable rights offering to
purchase additional shares of common stock of the Fund (the «Offering») as the Fund's registration statement has been declared effective by the Securities and Exchange Commission.
In connection with the acquisition of XA Secure, the Company also issued 265,012
shares of restricted stock, issued 318,966 options to
purchase the Company's common stock and may be required to pay an
additional $ 3.92 million to certain key employee - shareholders of XA Secure.
(d) by causing Retrophin to pay cash to himself, Biestek, and Fernandez so that he would not have to invest $ 731,778 of his own funds in the February PIPE, and by using PIPE proceeds in contravention of the terms of the Securities
Purchase Agreement to fund investments by Shkreli, Biestek and Fernandez, resulting in an
additional benefit to Shkreli alone of $ 360,000 in cash and 180,000 Retrophin
shares and warrants worth more than $ 5.3 million (at current market prices).
Simply stated a DRIP is a Dividend Reinvestment Plan whereby dividend distributions from your stock holdings are reinvested to
purchase additional shares.
In making this determination, the underwriters will consider, among other things, the price of
shares available for
purchase in the open market compared to the price at which the underwriters may
purchase shares through the option to
purchase additional shares.
The table above does not include (i) 5,952,917
shares of Class A common stock reserved for issuance under our 2015 Incentive Award Plan (as described in «Executive Compensation — New Employment Agreements and Incentive Plans»), consisting of (x) 2,689,486
shares of Class A common stock issuable upon exercise of options to
purchase shares of Class A common stock granted on the date of this prospectus to our directors and certain employees, including the named executive officers, in connection with this offering as described in «Executive Compensation — Director Compensation» and «Executive Compensation — New Equity Awards,» and (y) 3,263,431
additional shares of Class A common stock reserved for future issuance and (ii) 24,269,792
shares of Class A common stock issuable to the Continuing SSE Equity Owners upon redemption or exchange of their LLC Interests as described in «Certain Relationships and Related Party Transactions — SSE Holdings LLC Agreement.»
If any
additional shares of Class A common stock are
purchased, the underwriters will offer the
additional shares on the same terms as those on which the
shares are being offered.
You will experience
additional dilution when those holding options exercise their right to
purchase common stock under our equity incentive plans, when RSUs vest and settle, when we issue restricted stock to our employees under our equity incentive plans, or when we otherwise issue
additional shares of our common stock.
Except as otherwise indicated, the discussion and the tables above assume no exercise of the underwriters» option to
purchase additional shares of Class A common stock.
The table assumes no exercise by the underwriters of their option to
purchase additional shares of Class A common stock.
The adjustment assumes there will be no
additional distribution in the event the gross proceeds from the offering exceed the anticipated gross proceeds (including as a result of the exercise by the underwriters of their option to
purchase additional shares of Class A common stock).
The underwriters have 30 days from the date of this prospectus to exercise this option to
purchase additional shares.
The Company's board of directors also approved an
additional distribution to its members, to the extent the gross proceeds of the Company's planned initial public offering exceed the anticipated gross proceeds (including as a result of the exercise by the underwriters of their option to
purchase additional shares of Class A common stock), in an amount equal to the product of (A) the increased gross proceeds and (B) 0.273, to be paid from the proceeds of the Company's planned initial public offering.
On the date the
shares subject to this offering are priced, each non-employee director who, as of the date of this offering, is serving on our board of directors and is expected to continue his or her service following this offering will be granted (a) an option to
purchase shares of our Class A common stock with a grant date fair value of $ 50,000 (or, if such director is unaffiliated with any significant stockholder of the Company, $ 75,000) and (b) to the extent such director is (i) unaffiliated with any significant stockholder of the Company and (ii) the chairman of any committee of our board of directors, an
additional option to
purchase shares of our Class A common stock with a fair value of $ 10,000 with respect to each such chairmanship.
The underwriters may close out any covered short position either by exercising their option to
purchase additional shares, in whole or in part, or by
purchasing shares in the open market.
The diagram below depicts our organizational structure immediately following this offering assuming no exercise by the underwriters of their option to
purchase additional shares of Class A common stock.
Upon the completion of this offering and after giving effect to the planned recapitalization of our common stock into a single class of common stock and stock split, SIH will own
shares of our outstanding common stock (representing % of the
shares outstanding), our founders and their family trusts will own an aggregate
shares of our outstanding common stock (representing % of the
shares outstanding) and our employees who received
shares upon the liquidation of the special purpose employee ownership vehicle will own
shares of our outstanding common stock under a restricted stock award (representing % of the
shares outstanding), in each case as it relates to the percentage ownership assuming that the underwriters do not exercise their option to
purchase additional shares.
Our principal stockholders, funds affiliated with or related to Cyrus Capital Partners, L.P. (which we refer to in this prospectus collectively as «Cyrus Capital») and affiliates of Virgin Group Holdings Limited (which we refer to in this prospectus collectively as the «Virgin Group»), as selling stockholders, have granted the underwriters an option to
purchase up to
additional shares of common stock at the initial public offering price less the underwriting discount solely to cover overallotments.
Following the 2014 Recapitalization, we may have
additional outstanding warrants to
purchase shares of our common stock.
QS Investors LLC now owns 75,620
shares of the biopharmaceutical company's stock worth $ 2,358,000 after
purchasing an
additional 3,771
shares in the last quarter.
American International Group Inc. now owns 51,539
shares of the biopharmaceutical company's stock worth $ 1,607,000 after
purchasing an
additional 2,255
shares in the last quarter.
William Blair Investment Management LLC now owns 1,762,619
shares of the medical device company's stock worth $ 101,157,000 after
purchasing an
additional 344,294
shares in the last quarter.
The Company has granted the Agents an over-allotment option, exercisable in whole or in part, for a period of 30 days following the closing of the Offering, to
purchase up to an
additional 4,726,500 Units at $ 3.65 per Unit, 4,726,500 Common
Shares at the price of $ 3.62 per
Share or 2,363,250 Warrants at the price of $ 0.06 per Warrant, or any combination thereof.
Victory Capital Management Inc. now owns 485,087
shares of the insurance provider's stock valued at $ 33,422,000 after
purchasing an
additional 70,992
shares during the period.
Zurcher Kantonalbank Zurich Cantonalbank now owns 4,662
shares of the biopharmaceutical company's stock worth $ 145,000 after
purchasing an
additional 2,698
shares in the last quarter.
AXA now owns 1,911,206
shares of the medical device company's stock worth $ 109,684,000 after
purchasing an
additional 592,275
shares in the last quarter.
OppenheimerFunds Inc. now owns 1,495,535
shares of the medical device company's stock worth $ 85,829,000 after
purchasing an
additional 734,325
shares in the last quarter.
The firm owned 20,436
shares of the insurance provider's stock after
purchasing an
additional 7,731
shares during the quarter.
Crestline Management LP now owns 68,856
shares of the biopharmaceutical company's stock worth $ 2,147,000 after
purchasing an
additional 3,437
shares in the last quarter.